Sun Pharma Advanced Research Company's Stock Faces Negative Outlook and Decline

Sun Pharma Advanced Research Company (SPARC) has been facing a downward trend in its stock performance, with a loss of -5.0% on April 25, 2024. This has led to a 'Strong Sell' call by MarketsMOJO, indicating a negative outlook for the company's stock.

The stock has been underperforming the sector by -5.21% and has been on a consecutive fall for the last 11 days, with a total decline of -40.27% during this period. On the day of the report, the stock opened with a gap down of -5% and touched an intraday low of Rs 271.8.

Currently, the stock is trading at the same price as its opening, indicating a lack of range for the day. In terms of moving averages, SPARC is trading below its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages, further highlighting its downward trend.

In comparison to the Sensex, SPARC's performance has been significantly lower, with a -5.00% decline in just one day, while the Sensex only saw a -0.22% decrease. Over the past month, SPARC's performance has been even worse, with a -27.51% decline, while the Sensex saw a positive growth of 1.18%.

Overall, Sun Pharma Advanced Research Company's stock performance has been on a downward trend, with a negative outlook from MarketsMOJO. Investors should keep an eye on the company's performance and market trends before making any investment decisions.